FRIIF yields 15.53% · JNJ yields 2.13%● Live data
📍 FRIIF pulled ahead of the other in Year 1
Combined, FRIIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FRIIF + JNJ for your $10,000?
MGI Digital Technology Société Anonyme designs, manufactures, and sells digital printing and finishing solutions for the graphic arts industry in France and internationally. The company's products include AlphaJET, a factory 4.0 solution for the printing and packaging sector that displaces traditional production processes; JETvarnish 3D Web and JETvarnish 3D Web Color+, a roll-to-roll finishing solution; JETvarnish 3D Evolution, a spot UV coating solution; JETvarnish 3D, a solution for 3D or traditional flat spot UV coating; JETVARNISH 3DS, a digital solution; and JETvarnish 3D One, a digital print enrichment finishing presses. Its products also comprise PressCard Pro, an industrial production unit dedicated to the short run lamination of plastic substrates; and PunchCard Pro, a semi-automatic card punching unit. The company serves commercial printing, publishing, packaging, web to print, photo products, to the trade, and labels markets. MGI Digital Technology Société Anonyme was founded in 1982 and is based in Fresnes, France.
Full FRIIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.